See every side of every news story
Published loading...Updated

Trump's pharmaceutical tariffs could affect some drugmakers more than others

UNITED STATES, JUL 29 – Tariffs on imported drugs may reduce free cash flow for some drugmakers and could prompt shifts in manufacturing and research spending, analysts say.

Summary by CNBC
AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 83% of the sources lean Left
83% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

NBC Miami broke the news in Miami, United States on Tuesday, July 29, 2025.
Sources are mostly out of (0)